Skip to main content
. 2020 Jun 4;60(9):1198–1208. doi: 10.1002/jcph.1616

Figure 1.

Figure 1

Individual and median ex vivo platelet aggregation vs time (left). Individual and median ex vivo platelet aggregation vs glenzocimab plasma concentrations (right). Doses in milligrams.